{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T22:01:12Z","timestamp":1774130472470,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T00:00:00Z","timestamp":1571011200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T00:00:00Z","timestamp":1571011200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100017577","name":"Zhejiang Basic Public Welfare Research Project","doi-asserted-by":"crossref","award":["LGF19H100002"],"award-info":[{"award-number":["LGF19H100002"]}],"id":[{"id":"10.13039\/501100017577","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Pediatr"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s12519-019-00256-0","type":"journal-article","created":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T08:11:17Z","timestamp":1571040677000},"page":"89-98","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Clinical and laboratory features, treatment, and outcomes of macrophage activation syndrome in 80 children: a multi-center study in China"],"prefix":"10.1007","volume":"16","author":[{"given":"Li-Xia","family":"Zou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Hui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si-Rui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua-Song","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Hong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Guo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Ping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4930-9493","authenticated-orcid":false,"given":"Mei-Ping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,14]]},"reference":[{"key":"256_CR1","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1309\/AJCP4ZDKJ4ICOUAT","volume":"139","author":"FG Rosado","year":"2013","unstructured":"Rosado FG, Kim AS. Hemophagocytic lymphohistiocytosis: an update on diagnosis and pathogenesis. Am J Clin Pathol. 2013;139:713\u201327.","journal-title":"Am J Clin Pathol"},{"key":"256_CR2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.blre.2014.03.002","volume":"28","author":"GE Janka","year":"2014","unstructured":"Janka GE, Lehmberg K. Hemophagocytic syndromes\u2014an update. Blood Rev. 2014;28:135\u201342.","journal-title":"Blood Rev"},{"key":"256_CR3","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s10067-013-2227-1","volume":"32","author":"S Vilaiyuk","year":"2013","unstructured":"Vilaiyuk S, Sirachainan N, Wanitkun S, Pirojsakul K, Vaewpanich J. Recurrent macrophage activation syndrome as the primary manifestation in systemic lupus erythematosus and the benefit of serial ferritin measurements: a case-based review. Clin Rheumatol. 2013;32:899\u2013904.","journal-title":"Clin Rheumatol"},{"key":"256_CR4","first-page":"1133","volume":"34","author":"EM Behrens","year":"2007","unstructured":"Behrens EM, Beukelman T, Paessler M, Cron RQ. Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. J Rheumatol. 2007;34:1133\u20138.","journal-title":"J Rheumatol"},{"key":"256_CR5","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/MPH.0b013e3181dccbf4","volume":"32","author":"GA Latino","year":"2010","unstructured":"Latino GA, Manlhiot C, Yeung RS, Chahal N, McCrindle BW. Macrophage activation syndrome in the acute phase of Kawasaki disease. J Pediatr Hematol Oncol. 2010;32:527\u201331.","journal-title":"J Pediatr Hematol Oncol"},{"key":"256_CR6","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1002\/art.38802","volume":"66","author":"F Minoia","year":"2014","unstructured":"Minoia F, Dav\u00ec S, Horne A, Demirkaya E, Bovis F, Li C, et al. Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients. Arthritis Rheumatol. 2014;66:3160\u20139.","journal-title":"Arthritis Rheumatol"},{"key":"256_CR7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s12519-008-0018-6","volume":"4","author":"HS Zeng","year":"2008","unstructured":"Zeng HS, Xiong XY, Wei YD, Wang HW, Luo XP. Macrophage activation syndrome in 13 children with systemic-onset juvenile idiopathic arthritis. World J Pediatr. 2008;4:97\u2013101.","journal-title":"World J Pediatr."},{"key":"256_CR8","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1002\/art.24883","volume":"60","author":"A Parodi","year":"2009","unstructured":"Parodi A, Dav\u00ec S, Pringe AB, Pistorio A, Ruperto N, Magni-Manzoni S, et al. Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients. Arthritis Rheum. 2009;60:3388\u201399.","journal-title":"Arthritis Rheum"},{"key":"256_CR9","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1177\/0961203307079078","volume":"16","author":"A Pringe","year":"2007","unstructured":"Pringe A, Trail L, Ruperto N, Buoncompagni A, Loy A, Breda L, et al. Macrophage activation syndrome in juvenile systemic lupus erythematosus: an under-recognized complication? Lupus. 2007;16:587\u201392.","journal-title":"Lupus."},{"key":"256_CR10","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/MPH.0000000000000872","volume":"39","author":"S Garc\u00eda-Pav\u00f3n","year":"2017","unstructured":"Garc\u00eda-Pav\u00f3n S, Yamazaki-Nakashimada MA, B\u00e1ez M, Borjas-Aguilar KL, Murata C. Kawasaki disease complicated with macrophage activation syndrome: a systematic review. J Pediatr Hematol Oncol. 2017;39:445\u201351.","journal-title":"J Pediatr Hematol Oncol"},{"key":"256_CR11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/gene.2012.3","volume":"13","author":"A Ravelli","year":"2012","unstructured":"Ravelli A, Grom AA, Behrens EM, Cron RQ. Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment. Genes Immun. 2012;13:289\u201398.","journal-title":"Genes Immun"},{"key":"256_CR12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1586\/eci.09.58","volume":"6","author":"S Gupta","year":"2010","unstructured":"Gupta S, Weitzman S. Primary and secondary hemophagocytic lymphohistiocytosis: clinical features, pathogenesis and therapy. Expert Rev Clin Immunol. 2010;6:137\u201354.","journal-title":"Expert Rev Clin Immunol."},{"key":"256_CR13","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390\u20132.","journal-title":"J Rheumatol"},{"key":"256_CR14","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1542\/peds.2004-2182","volume":"114","author":"JW Newburger","year":"2004","unstructured":"Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics. 2004;114:1708\u201333.","journal-title":"Pediatrics"},{"key":"256_CR15","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.","journal-title":"Arthritis Rheum"},{"key":"256_CR16","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/rheumatology\/kel025","volume":"45","author":"VE Brown","year":"2006","unstructured":"Brown VE, Pilkington CA, Feldman BM, Davidson JE, Network for Juvenile Dermatomyositis, Paediatric Rheumatology European Society (PReS). An international consensus survey of the diagnostic criteria for juvenile dermatomyositis (JDM). Rheumatology (Oxford). 2006;45:990\u20133.","journal-title":"Rheumatology (Oxford)"},{"key":"256_CR17","first-page":"41","volume-title":"Mixed connective tissue disease and antinuclear antibodies","author":"R Kasukawa","year":"1987","unstructured":"Kasukawa R, Sharp GC. Preliminary diagnostic criteria for classification of mixed connective tissue disease. In: Kasukawa R, Sharp GC, editors. Mixed connective tissue disease and antinuclear antibodies. Amsterdam: Elsevier; 1987. p. 41\u20138."},{"key":"256_CR18","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1136\/ard.2005.046300","volume":"65","author":"S Ozen","year":"2006","unstructured":"Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, et al. EULAR\/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis. 2006;65:936\u201341.","journal-title":"Ann Rheum Dis"},{"key":"256_CR19","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jpeds.2004.12.016","volume":"146","author":"A Ravelli","year":"2005","unstructured":"Ravelli A, Magni-Manzoni S, Pistorio A, Besana C, Foti T, Ruperto N, et al. Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. J Pediatr. 2005;146:598\u2013604.","journal-title":"J Pediatr"},{"key":"256_CR20","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/art.39332","volume":"68","author":"A Ravelli","year":"2016","unstructured":"Ravelli A, Minoia F, Dav\u00ec S, Horne A, Bovis F, Pistorio A, et al. 2016 Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism\/American College of Rheumatology\/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Arthritis Rheumatol. 2016;68:566\u201376.","journal-title":"Arthritis Rheumatol."},{"key":"256_CR21","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, Horne A, Aric\u00f3 M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124\u201331.","journal-title":"Pediatr Blood Cancer"},{"key":"256_CR22","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.semarthrit.2014.07.007","volume":"44","author":"W Wang","year":"2015","unstructured":"Wang W, Gong F, Zhu W, Fu S, Zhang Q. Macrophage activation syndrome in Kawasaki disease: more common than we thought? Semin Arthritis Rheum. 2015;44:405\u201310.","journal-title":"Semin Arthritis Rheum"},{"key":"256_CR23","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/art.40417","volume":"70","author":"RE Borgia","year":"2018","unstructured":"Borgia RE, Gerstein M, Levy DM, Silverman ED, Hiraki LT. Features, treatment, and outcomes of macrophage activation syndrome in childhood-onset systemic lupus erythematosus. Arthritis Rheumatol. 2018;70:616\u201324.","journal-title":"Arthritis Rheumatol."},{"key":"256_CR24","first-page":"1414","volume":"16","author":"M Atteritano","year":"2012","unstructured":"Atteritano M, David A, Bagnato G, Beninati C, Frisina A, Iaria C, et al. Haemophagocytic syndrome in rheumatic patients. A systematic review. Eur Rev Med Pharmacol Sci. 2012;16:1414\u201324.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"256_CR25","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3389\/fped.2018.00374","volume":"6","author":"AH Rowley","year":"2018","unstructured":"Rowley AH, Shulman ST. The epidemiology and pathogenesis of Kawasaki disease. Front Pediatr. 2018;6:374.","journal-title":"Front Pediatr."},{"key":"256_CR26","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00296-016-3545-9","volume":"36","author":"S Ayta\u00e7","year":"2016","unstructured":"Ayta\u00e7 S, Batu ED, \u00dcnal \u015e, Bilginer Y, \u00c7etin M, Tuncer M, et al. Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus. Rheumatol Int. 2016;36:1421\u20139.","journal-title":"Rheumatol Int"},{"key":"256_CR27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10067-017-3625-6","volume":"37","author":"AC Liu","year":"2018","unstructured":"Liu AC, Yang Y, Li MT, Jia Y, Chen S, Ye S, et al. Macrophage activation syndrome in systemic lupus erythematosus: a multicenter, case\u2013control study in China. Clin Rheumatol. 2018;37:93\u2013100.","journal-title":"Clin Rheumatol"},{"key":"256_CR28","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1080\/20469047.2018.1511028","volume":"38","author":"HF Yang","year":"2018","unstructured":"Yang HF, Fan HC. Kawasaki disease shock syndrome and macrophage activation syndrome. Paediatr Int Child Health. 2018;38:310.","journal-title":"Paediatr Int Child Health."},{"key":"256_CR29","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jbspin.2013.09.004","volume":"81","author":"A Lef\u00e8vre-Utile","year":"2014","unstructured":"Lef\u00e8vre-Utile A, Galeotti C, Kon\u00e9-Paut I. Coronary artery abnormalities in children with systemic-onset juvenile idiopathic arthritis. Jt Bone Spine. 2014;81:257\u20139.","journal-title":"Jt Bone Spine."},{"key":"256_CR30","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jpeds.2015.02.003","volume":"166","author":"S Dong","year":"2015","unstructured":"Dong S, Bout-Tabaku S, Texter K, Jaggi P. Diagnosis of systemic-onset juvenile idiopathic arthritis after treatment for presumed Kawasaki disease. J Pediatr. 2015;166:1283\u20138.","journal-title":"J Pediatr"},{"key":"256_CR31","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/ar3843","volume":"14","author":"SF Bode","year":"2012","unstructured":"Bode SF, Lehmberg K, Maul-Pavicic A, Vraetz T, Janka G, Stadt UZ, et al. Recent advances in the diagnosis and treatment of hemophagocytic lymphohistiocytosis. Arthritis Res Ther. 2012;14:213.","journal-title":"Arthritis Res Ther."},{"key":"256_CR32","doi-asserted-by":"crossref","first-page":"e000161","DOI":"10.1136\/rmdopen-2015-000161","volume":"2","author":"A Ravelli","year":"2016","unstructured":"Ravelli A, Minoia F, Davi S, Horne A, Bovis F, Pistorio A, et al. Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. RMD Open. 2016;2:e000161.","journal-title":"RMD Open."},{"key":"256_CR33","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.semarthrit.2014.09.004","volume":"44","author":"MM Kostik","year":"2015","unstructured":"Kostik MM, Dubko MF, Masalova VV, Snegireva LS, Kornishina TL, Chikova IA, et al. Identification of the best cutoff points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis. Semin Arthritis Rheum. 2015;44:417\u201322.","journal-title":"Semin Arthritis Rheum."},{"key":"256_CR34","first-page":"230","volume":"132","author":"U Emmenegger","year":"2002","unstructured":"Emmenegger U, Reiiomers A, Frey U, Fux Ch, Bihl F, Semela D, et al. Reactive macrophage activation syndrome: a simple screening strategy and its potential in early treatment initiation. Swiss Med Wkly. 2002;132:230\u20136.","journal-title":"Swiss Med Wkly."},{"key":"256_CR35","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.3899\/jrheum.121131","volume":"40","author":"M Gorelik","year":"2013","unstructured":"Gorelik M, Fall N, Altaye M, Barnes MG, Thompson SD, Grom AA, et al. Follistatin-like protein 1 and the ferritin\/erythrocyte sedimentation rate ratio are potential biomarkers for dysregulated gene expression and macrophage activation syndrome in systemic juvenile idiopathic arthritis. J Rheumatol. 2013;40:1191\u20139.","journal-title":"J Rheumatol"},{"key":"256_CR36","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1136\/adc.85.5.421","volume":"85","author":"S Sawhney","year":"2001","unstructured":"Sawhney S, Woo P, Murray K. Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child. 2001;85:421\u20136.","journal-title":"Arch Dis Child"},{"key":"256_CR37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12969-015-0055-3","volume":"13","author":"V Boom","year":"2015","unstructured":"Boom V, Anton J, Lahdenne P, Quartier P, Ravelli A, Wulffraat NM, et al. Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2015;13:55.","journal-title":"Pediatr Rheumatol Online J."},{"key":"256_CR38","first-page":"108","volume":"19","author":"A Ravelli","year":"2001","unstructured":"Ravelli A, Viola S, De Benedetti F, Magni-Manzoni S, Tzialla C, Martini A. Dramatic efficacy of cyclosporine A in macrophage activation syndrome. Clin Exp Rheumatol. 2001;19:108.","journal-title":"Clin Exp Rheumatol"},{"key":"256_CR39","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3899\/jrheum.140288","volume":"42","author":"S Yokota","year":"2015","unstructured":"Yokota S, Itoh Y, Morio T, Sumitomo N, Daimaru K, Minota S. Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis under treatment with tocilizumab. J Rheumatol. 2015;42:712\u201322.","journal-title":"J Rheumatol"},{"key":"256_CR40","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3109\/s10165-010-0348-9","volume":"21","author":"M Kobayashi","year":"2011","unstructured":"Kobayashi M, Takahashi Y, Yamashita H, Kaneko H, Mimori A. Benefit and a possible risk of tocilizumab therapy for adult-onset Still\u2019s disease accompanied by macrophage-activation syndrome. Mod Rheumatol. 2011;21:92\u20136.","journal-title":"Mod Rheumatol"},{"key":"256_CR41","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.cyto.2012.02.006","volume":"58","author":"M Shimizu","year":"2012","unstructured":"Shimizu M, Nakagishi Y, Kasai K, Yamasaki Y, Miyoshi M, Takei S, et al. Tocilizumab masks the clinical symptoms of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome: the diagnostic significance of interleukin-18 and interleukin-6. Cytokine. 2012;58:287\u201394.","journal-title":"Cytokine"},{"key":"256_CR42","first-page":"1","volume":"00","author":"Z Kiuchi","year":"2018","unstructured":"Kiuchi Z, Ogura M, Sato M, Kamei K, Ishikura K, Abe J, et al. No preventive or therapeutic efficacy of infliximab against macrophage activation syndrome due to systemic juvenile idiopathic arthritis. Scand J Rheumatol. 2018;00:1\u20133.","journal-title":"Scand J Rheumatol"},{"key":"256_CR43","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/jca.21570","volume":"33","author":"N Kinjo","year":"2018","unstructured":"Kinjo N, Hamada K, Hirayama C, Shimizu M. Role of plasma exchange, leukocytapheresis, and plasma diafiltration in management of refractory macrophage activation syndrome. J Clin Apheresis. 2018;33:117\u201320.","journal-title":"J Clin Apheresis"},{"key":"256_CR44","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13287-018-0941-y","volume":"9","author":"H Sevim","year":"2018","unstructured":"Sevim H, Kocaefe Y\u00c7, Onur MA, U\u00e7kan-\u00c7etinkaya D, G\u00fcrp\u0131nar \u00d6A. Bone marrow derived mesenchymal stem cells ameliorate inflammatory response in an in vitro model of familial hemophagocytic lymphohistiocytosis 2. Stem Cell Res Ther. 2018;9:198.","journal-title":"Stem Cell Res Ther"},{"key":"256_CR45","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1002\/art.34661","volume":"64","author":"TD Bennett","year":"2012","unstructured":"Bennett TD, Fluchel M, Hersh AO, Hayward KN, Hersh AL, Brogan TV, et al. Macrophage activation syndrome in children with systemic lupus erythematosus and children with juvenile idiopathic arthritis. Arthritis Rheum. 2012;64:4135\u201342.","journal-title":"Arthritis Rheum"},{"key":"256_CR46","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1002\/art.38672","volume":"66","author":"S Kumakura","year":"2014","unstructured":"Kumakura S, Murakawa Y. Clinical characteristics and treatment outcomes of autoimmune-associated hemophagocytic syndrome in adults. Arthritis Rheumatol. 2014;66:2297\u2013307.","journal-title":"Arthritis Rheumatol."}],"container-title":["World Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-019-00256-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12519-019-00256-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-019-00256-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T23:28:22Z","timestamp":1602545302000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12519-019-00256-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,14]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["256"],"URL":"https:\/\/doi.org\/10.1007\/s12519-019-00256-0","relation":{},"ISSN":["1708-8569","1867-0687"],"issn-type":[{"value":"1708-8569","type":"print"},{"value":"1867-0687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,14]]},"assertion":[{"value":"15 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study was approved by the Research Ethics Committees of the Children\u2019s Hospital, Zhejiang University School of Medicine (2018-IRB-032).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No financial or nonfinancial benefits have been received or will be received from any party related directly or indirectly to the subject of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}